Clinical Trials Logo
  1. Home
  2. Glaucoma
  3. NCT06266351
  4. Details
NCT06266351 Clinical Trial

EVALUATION OF CATS TONOMETER PRISM IN LASIK SUBJECTS

Glaucoma Clinical Trial

Official title:
EVALUATION OF CATS TONOMETER PRISM IN LASIK SUBJECTS

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06266351
Other study ID # LASIKIOP
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 12, 2024
Est. completion date August 1, 2024

Study information
Verified date February 2024
Source Intuor Technologies, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The CATS Tonometer prism clinical study is intended to determine repeatability of intraocular pressure measurement in human corneas which have undergone a LASIK procedure when compared to a standard Goldmann prism, validating the human LASIK eye findings comparing CATS Tonometer and Goldmann prisms to intracameral pressure in cadaver eyes.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 150
Est. completion date August 1, 2024
Est. primary completion date June 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: Subjects must meet the following inclusion criteria to be eligible to participate in this clinical trial: - At least 22 years of age and undergone LASIK treatment - Subject has a clear understanding, English speakingand agrees to all the conditions of the informed consent form Exclusion Criteria: - Subjects will be excluded from participation if they meet the following criteria: - Subject has undergone ocular surgery within the last 3 months or LASIK within 6 months - Pregnant or nursing women - Those who have had previous corneal surgery excluding LASIK - Keratoconus - Corneal scarring - Microphthalmos - Buphthalmos - Dry eyes with clinical epithelial breakdown upon exam - Lid squeezers - blepharospasm - Nystagmus - Corneal or conjunctival infection.

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• This is observational IOP measurement
IOP measurement of patients having LASIK with both CATS and GAT

Locations
Country Name City State
United States Eye Specialty Group Memphis Tennessee
United States Arizona Eye Consultants Tucson Arizona

Sponsors (1)
Lead Sponsor Collaborator
Intuor Technologies, Inc.

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary IOP measurement difference between CATS and GAT in LASIK patients IOP measurement single measurement 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02628223 - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma N/A
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A